David C Paul
CIK 1555391 · Executive Chairman · last filed 2026-01-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.86M
Companies
1
Total Filings
25
Lifetime Open-Market Net
-$234.68M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GMED | Executive Chairman | 60,417 | $80.39 | $4.86M | -$234.68M | 25 | 2026-01-23 |
Recent Filings · Page 2 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-11 | GMED | Grant (A) | — | $0 | EDGAR |
| 2018-09-26 | GMED | Mixed | −605,871 | -$111.42M | EDGAR |
| 2018-07-19 | GMED | Sell (S) | −6,841 | -$362.2K | EDGAR |
| 2018-04-30 | GMED | Mixed | −428,366 | -$33.56M | EDGAR |
| 2018-01-24 | GMED | Grant (A) | — | $0 | EDGAR |
| 2017-02-01 | GMED | Grant (A) | — | $0 | EDGAR |
| 2016-01-27 | GMED | Grant (A) | — | $0 | EDGAR |
| 2015-03-20 | GMED | Sell (S) | −1,922,000 | -$48.05M | EDGAR |
| 2015-03-02 | GMED | Mixed | +3,000,000 | $0 | EDGAR |
| 2015-01-22 | GMED | Mixed | +3,000,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.